Genovate Biotechnology Market Cap

Genovate Biotechnology has a market cap or net worth of 3.19 billion as of April 28, 2026. Its market cap has increased by 29.82% in one year.

Market Cap

3.19B

Enterprise Value

2.70B

Revenue

492.41M

Ranking

n/a

PE Ratio

280.00

Stock Price

28.05

Market Cap Chart

Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.19B, an increase of 379.09%. That is a compound annual growth rate of 9.37%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	3.19B	1.08%
Dec 31, 2025	3.15B	35.56%
Dec 31, 2024	2.32B	-20.11%
Dec 29, 2023	2.91B	-17.02%
Dec 30, 2022	3.51B	31.05%
Dec 30, 2021	2.68B	-15.11%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SYN-TECH Chem. & Pharm.	3.15B
Intech Biopharm	3.23B
Shine-On BioMedical	3.30B
BRIM Biotechnology	3.05B
HeXun Biosciences	2.96B
Apex Biotechnology	2.88B
Syngen Biotech	2.82B
BioGend Therapeutics	3.61B

Market Cap Rankings